COVID-19 Updates
Original Research
Dermatology Author Gender Trends During the COVID-19 Pandemic
The academic productivity of female dermatologists as last authors in dermatology clinical journals has potentially been impacted by the COVID-19...
From the Journals
Review supports continued mask-wearing in health care visits
Masks continue to lower the risk of catching the virus during medical visits.
Case Letter
New-Onset Pemphigoid Gestationis Following COVID-19 Vaccination
Dermatologists should be aware that COVID-19 messenger RNA vaccinations may present with various cutaneous complications. Pemphigoid gestationis...
Latest News
COVID-19 and psoriasis: Is there a link?
“Infection with COVID-19 has been associated with flares of guttate and pustular psoriasis, and even psoriasis that affects 100% of the skin.”
Feature
Researchers seek to understand post-COVID autoimmune disease risk
Three large studies link past SARS-CoV-2 infection to new-onset autoimmune disease, but it is not yet clear what drives this relationship.
Clinical Review
Skin Diseases Associated With COVID-19: A Narrative Review
We provide an overview of the dermatoses associated with the COVID-19 pandemic.
From the Journals
COVID-19 potentially induced adult-onset IgA vasculitis
A 41-year-old woman developed IgA vasculitis associated with pulmonary-renal syndrome after COVID-19 infection.
Latest News
One in four parents lied about kids’ COVID status: Survey
Many parents said they considered it their right as parents to make their own decision about their children’s health status.
Latest News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...
Feature
Inflammation and immunity troubles top long-COVID suspect list
“I think that it’s a much more complex picture than just inflammation, or just autoimmunity, or just immune dysregulation,” says expert.
Feature
COVID emergency orders ending: What’s next?
There will be cost-sharing changes for COVID-19 vaccines, testing, and certain treatments.